F
Faraday Pharmaceuticals, Inc.
Profile managed by Bizz IdFaraday Pharmaceuticals
Estados Unidos
1-10 employees
Description
Clinical-stage biopharmaceutical company headquartered in Seattle, Washington, developing drugs to prevent and treat cardiac and skeletal muscle loss. Its lead candidate FDY-5301 is in Phase 3 trial for acute myocardial infarction.